Scarica l'app Stockscreener
11.23
4.47%
0.48
Dopo l'orario di chiusura:
11.02
-0.21
-1.87%
Precedente Chiudi:
$10.75
Aprire:
$10.65
Volume 24 ore:
43,812
Relative Volume:
0.69
Capitalizzazione di mercato:
$26.64M
Reddito:
-
Utile/perdita netta:
$-3.34M
Rapporto P/E:
-4.16
EPS:
-2.6995
Flusso di cassa netto:
$-10.54M
1 W Prestazione:
-10.59%
1M Prestazione:
-0.88%
6M Prestazione:
-13.35%
1 anno Prestazione:
+95.29%
Intervallo 1D:
$10.42
$11.28
Intervallo di 1 settimana:
$10.32
$12.71
Portata 52W:
$2.88
$18.20
Polyrizon Ltd Stock (PLRZ) Company Profile
Compare PLRZ vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PLRZ
Polyrizon Ltd
|
11.23 | 25.50M | 0 | -3.34M | -10.54M | -2.6995 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Polyrizon Ltd Borsa (PLRZ) Ultime notizie
Biotech Polyrizon (PLRZ) completes new warrant funding - Stock Titan
Polyrizon (NASDAQ: PLRZ) Announces Offering of 232,500 Shares at $12.00 Plus 30,000 Pre-Funded Warrants - Kalkine Media
Polyrizon announces closing of registered direct offering - Medical Buyer
Polyrizon Raises $4 Million in Registered Direct Offering and Private Placement - TipRanks
Single investor funds new Polyrizon (PLRZ) cash raise - Stock Titan
Polyrizon Ltd. (PLRZ) Stock: Company Closes $4 Million Deal With Institutional Investor - Blockonomi
Polyrizon Ltd. Closes $4 Million Registered Direct Offering and Concurrent Private Placement - quiverquant.com
One investor puts about $4 million into Polyrizon - Stock Titan
$4M funding deal gives Polyrizon (PLRZ) investor long-term warrant rights - Stock Titan
Polyrizon raises $4 million in registered direct offering By Investing.com - Investing.com Nigeria
Polyrizon raises $4 million in registered direct offering - Investing.com
One investor agreed to buy Polyrizon shares and warrants; proceeds are expected at about $4 million. - Stock Titan
Polyrizon Tumbles on Clinical Studies - Baystreet.ca
Polyrizon completes contracting for allergy blocker trial sites - Investing.com
Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study - FinancialContent
symbol__ Stock Quote Price and Forecast - CNN
Polyrizon (PLRZ) Latest: Closes 6.26% Lower at $10.49 in the Current Update; Range Check: Support at $9.97 and Resistance at $11.01 Frame the Range in Latest TradingWyckoff Accumulation - vinanet.vn
Polyrizon Finalizes U.S. Clinical Site Network for NASARIX Allergy Study - TipRanks
Polyrizon (PLRZ) lines up sites for 120-patient allergy study - Stock Titan
Polyrizon completes contracting with all five clinical sites By Investing.com - Investing.com South Africa
Polyrizon Completes Site Contracting for NASARIX™ Seasonal Allergic Rhinitis Study - Quiver Quantitative
Polyrizon's planned allergy study will compare its spray with saline in up to 120 patients - Stock Titan
Polyrizon completes contracting with all five clinical sites - Investing.com
Polyrizon (PLRZ) Close and Levels: Records a 5.65% Decrease to $10.36 for the Current Session; Nearby Levels: the Current Price Sits Inside the Supplied Technical Range in the Available RecordRectangle Pattern - vinanet.vn
Polyrizon Ltd. (PLRZ) Gains 2.14% to $10.98, Holding Support Amid Biotech InterestTPO Profile - vinanet.vn
Polyrizon Ltd. (PLRZ): MMCAP group discloses 9.6% beneficial stake - Stock Titan
DISCLOSED: Insiders Are Now Buying *This Stock* Sootoday.com (Je9ZHM0WVP) - Mshale
Polyrizon Ltd (PLRZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Polyrizon Ltd. (PLRZ) Slips 2.24% as Shares Test Key Support Zone Near $10.76Volume Gap - vinanet.vn
PLRZ.O PE Ratio & Valuation, Is PLRZ.O Overvalued - Intellectia AI
Polyrizon Ltd (PLRZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
Polyrizon Ltd (PLRZ) Institutional Confidence - TradingKey
Polyrizon Ltd (PLRZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Polyrizon Ltd (PLRZ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Polyrizon Ltd (PLRZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Polyrizon Ltd (PLRZ) Cash Flow - TradingKey
Polyrizon Ltd (PLRZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Polyrizon Ltd (PLRZ) Balance Sheet - TradingKey
TradingKey - TradingKey
Polyrizon Ltd (PLRZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com
Polyrizon Ltd. Revenue Breakdown – NASDAQ:PLRZ - TradingView
PLRZ|Polyrizon Ltd|Price:13.800|Chg%:-0.880 - TradingKey
Polyrizon (PLRZ) Advances 3.23% as Stock Tests Key Resistance Near $14.09Volume Nodes - dars.gov.et
Polyrizon (PLRZ) Slips Slightly as Stock Hovers Near Support LevelsDescending Triangle - dars.gov.et
Polyrizon Shareholders Approve New Executive Compensation Policy on July 13, 2026 - TipRanks
Polyrizon (PLRZ) locks in 3-year executive and director pay policy - Stock Titan
Polyrizon Ltd. (PLRZ) Rises 2.09% as Shares Approach Resistance at $15.38Buyback Factor - dars.gov.et
Polyrizon Ltd. (PLRZ) Rallies 7.32% to $15.40 — Bulls Test Key ResistanceDouble Top - DonanımHaber
Polyrizon (PLRZ) Holds Steady Near Support as Stock Edges HigherOption Strike Build - dars.gov.et
Polyrizon retains Nasdaq listing following hearings panel - MSN
Polyrizon Clears Key Safety Milestone for NASARIX Allergy Nasal Spray - TipRanks
Polyrizon Ltd Azioni (PLRZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):